Using the cutoff ≥ 20% for CD38 expression by flow cytometry as an indicator of positivity, mature B-cell lymphoma patients were divided into CD38 positive (No. = 48) and CD38 negative (No. = 42) patients. Here, CD38 is linked to B-cell non-Hodgkin lymphoma.